BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30011807)

  • 1. Autoantibodies as Potential Biomarkers in Breast Cancer.
    Qiu J; Keyser B; Lin ZT; Wu T
    Biosensors (Basel); 2018 Jul; 8(3):. PubMed ID: 30011807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for early detection of breast cancer: what, when, and where?
    Levenson VV
    Biochim Biophys Acta; 2007 Jun; 1770(6):847-56. PubMed ID: 17368950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multiparametric serum marker panel as a complementary test to mammography for the diagnosis of node-negative early-stage breast cancer and DCIS in young women.
    Lacombe J; Mangé A; Bougnoux AC; Prassas I; Solassol J
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1834-42. PubMed ID: 24957886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blueprint of quartz crystal microbalance biosensor for early detection of breast cancer through salivary autoantibodies against ATP6AP1.
    Arif S; Qudsia S; Urooj S; Chaudry N; Arshad A; Andleeb S
    Biosens Bioelectron; 2015 Mar; 65():62-70. PubMed ID: 25461139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers.
    Lacombe J; Mangé A; Jarlier M; Bascoul-Mollevi C; Rouanet P; Lamy PJ; Maudelonde T; Solassol J
    Int J Cancer; 2013 Mar; 132(5):1105-13. PubMed ID: 22886747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-Associated Autoantibodies as Diagnostic Biomarkers for Breast Cancer: A Systematic Review and Meta-Analysis.
    Xia J; Shi J; Wang P; Song C; Wang K; Zhang J; Ye H
    Scand J Immunol; 2016 Jun; 83(6):393-408. PubMed ID: 26991924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of autoantibodies to detect the onset of breast cancer.
    Lacombe J; Mangé A; Solassol J
    J Immunol Res; 2014; 2014():574981. PubMed ID: 25143958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosensor-based diagnostic approaches for various cellular biomarkers of breast cancer: A comprehensive review.
    Ranjan P; Parihar A; Jain S; Kumar N; Dhand C; Murali S; Mishra D; Sanghi SK; Chaurasia JP; Srivastava AK; Khan R
    Anal Biochem; 2020 Dec; 610():113996. PubMed ID: 33080213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies in Early Detection of Breast Cancer.
    Rauf F; Anderson KS; LaBaer J
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2475-2485. PubMed ID: 32994341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer.
    Mao J; Ladd J; Gad E; Rastetter L; Johnson MM; Marzbani E; Childs JS; Lu H; Dang Y; Broussard E; Stanton SE; Hanash SM; Disis ML
    J Transl Med; 2014 May; 12():121. PubMed ID: 24886063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays: application to the sensitive and specific detection of tumor markers from breast cancer sera.
    Yang Z; Chevolot Y; Géhin T; Solassol J; Mange A; Souteyrand E; Laurenceau E
    Biosens Bioelectron; 2013 Feb; 40(1):385-92. PubMed ID: 23017679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Advent of Salivary Breast Cancer Biomarker Detection Using Affinity Sensors.
    Abrao Nemeir I; Saab J; Hleihel W; Errachid A; Jafferzic-Renault N; Zine N
    Sensors (Basel); 2019 May; 19(10):. PubMed ID: 31126047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis.
    Fernández Madrid F
    Cancer Lett; 2005 Dec; 230(2):187-98. PubMed ID: 16297705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crucial considerations for pipelines to validate circulating biomarkers for breast cancer.
    Ewaisha R; Gawryletz CD; Anderson KS
    Expert Rev Proteomics; 2016; 13(2):201-11. PubMed ID: 26653344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies in breast cancer.
    Fernández-Madrid F; Maroun MC
    Adv Clin Chem; 2014; 64():221-40. PubMed ID: 24938020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibody profiles as biomarkers of breast cancer.
    Tabernero MD; Lv LL; Anderson KS
    Cancer Biomark; 2010; 6(5-6):247-56. PubMed ID: 20938085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of autoantibodies in breast cancer screening and diagnosis.
    Storr SJ; Chakrabarti J; Barnes A; Murray A; Chapman CJ; Robertson JF
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1215-23. PubMed ID: 16925487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Protein Markers for the Early Detection of Lung Cancer: A Focus on Autoantibodies.
    Broodman I; Lindemans J; van Sten J; Bischoff R; Luider T
    J Proteome Res; 2017 Jan; 16(1):3-13. PubMed ID: 27769114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer.
    Henderson MC; Hollingsworth AB; Gordon K; Silver M; Mulpuri R; Letsios E; Reese DE
    PLoS One; 2016; 11(8):e0157692. PubMed ID: 27508384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.